Gonzalez-Cadavid; Nestor F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gonzalez-Cadavid; Nestor F..The latest application filed is for "microrna transcriptional signature (mir-ts) evaluation of stem cells".

Company Profile

1.4.9

Gonzalez-Cadavid; Nestor F. - Pasadena CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MicroRNA Transcriptional Signature (miR-TS) Evaluation of Stem Cells App 20210189490 - Gonzalez-Cadavid; Nestor F.	2021-06-24
Methods Of Use Of Inhibitors Of Phosphodiesterases And Modulators Of Nitric Oxide, Reactive Oxygen Species, And Metalloproteinas App 20200000811 - GONZALEZ-CADAVID; Nestor F. ; et al.	2020-01-02
Methods Of Use Of Inhibitors Of Phosphodiesterases And Modulators Of Nitric Oxide, Reactive Oxygen Species, And Metalloproteinases In The Treatment Of Peyronie's Disease, Arteriosclerosis And Other Fibrotic Diseases App 20180318307 - GONZALEZ-CADAVID; Nestor F. ; et al.	2018-11-08
Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases App 20170239257 - Gonzalez-Cadavid; Nestor F. ; et al.	2017-08-24
Modulation Of Myofiber Repair By Anti-myostatin Strategies And/or Ppar Gamma Ligands, Alone Or In Combination With Stem Cells, For The Therapy Of Critical Limb Ischemia And Other Ischemic Processes Affecting The Skeletal Muscle App 20150328249 - Gonzalez-Cadavid; Nestor F. ; et al.	2015-11-19
Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases App 20140350021 - Gonzalez-Cadavid; Nestor F. ; et al.	2014-11-27
Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases App 20140200219 - Gonzalez-Cadavid; Nestor F. ; et al.	2014-07-17
Method for modifying myostatin expression Grant 8,426,374 - Magee , et al. April 23, 2	2013-04-23
Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic Diseases App 20120141454 - Gonzalez-Cadavid; Nestor F. ; et al.	2012-06-07
Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases Grant 8,133,903 - Gonzalez-Cadavid , et al. March 13, 2	2012-03-13
Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseases App 20050085486 - Gonzalez-Cadavid, Nestor F. ; et al.	2005-04-21
Amelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNA Grant 5,594,032 - Gonzalez-Cadavid , et al. January 14, 1	1997-01-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.